• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Austria·Industrials·SEM.VI
Share

Semperit AG Holding Stocks

€ 18.05Last Updated 05.11.2026

Issuer Rating

5/7
Performance

Strong

Risk

Moderate

Recommendation

Hold

Market Cap

€ 394.76M

€ 18.05
Key Takeaways

Risk factor

Poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Semperit AG Holding, founded in 1824 and based in Vienna, Austria, is a global company that specializes in the research, production, and sale of rubber goods for both the healthcare and industrial sectors. The organization conducts its business through five main divisions: Sempermed, Semperflex, Sempertrans, Semperform, and Semperseal. The Sempermed unit delivers examination and surgical gloves for medical applications, alongside protective gloves designed for industrial, commercial, and private use. Semperflex manufactures hydraulic and industrial hoses, which are utilized in various fields such as construction, transportation, mining, and agricultural machinery. The Sempertrans segment supplies textile and steel-cord conveyor belts, essential for operations in mining, steel production, cement manufacturing, civil engineering, general transport, and power generation facilities. Semperform's product range includes escalator handrails, rubber rings for ropeways, anti-vibration membranes for skis and snowboards, and custom-engineered injection-moulded and extruded parts with sealing or damping capabilities. Finally, the Semperseal division offers elastomer and sealing profiles for windows, doors, and facades, as well as wear-resistant protective sheeting made from elastomers.

Company Valuation

Greatly undervalued
7/7

Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers. In particular, the stock is underpriced on P/E, 'cheap' on EV/EBIT

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Neutral
4/7

The average target price of SEM.VI is 22.6 and suggests 25.4% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to in

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

07.11.2026 01:19

Goldman's Fear Index has skyrocketed to an extreme level. Is this a signal that stock prices will rise?

07.11.2026 00:39

Tesla will discontinue the Cybertruck in 2027 after several years of sluggish sales

06.11.2026 23:35

Microsoft Is Winding Down Its Deal with Oracle on AI Computing Power — Bloomberg

06.11.2026 22:16

An analyst who predicted the market crash called the potential event more important than the election

06.11.2026 21:48

Moderna's stock rose 700% on the back of its cancer vaccine. But COVID-19 is still important to revenue

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026